NewEdge Wealth LLC Acquires New Holdings in STERIS plc (NYSE:STE)

NewEdge Wealth LLC acquired a new stake in STERIS plc (NYSE:STE) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 1,108 shares of the medical equipment provider’s stock, valued at approximately $244,000.

Several other hedge funds have also recently bought and sold shares of STE. Yousif Capital Management LLC lifted its position in STERIS by 0.7% in the 1st quarter. Yousif Capital Management LLC now owns 15,327 shares of the medical equipment provider’s stock valued at $3,706,000 after purchasing an additional 106 shares during the last quarter. Vontobel Holding Ltd. raised its position in shares of STERIS by 25.6% during the 1st quarter. Vontobel Holding Ltd. now owns 1,919 shares of the medical equipment provider’s stock worth $471,000 after buying an additional 391 shares in the last quarter. Blair William & Co. IL raised its position in shares of STERIS by 8.1% during the 1st quarter. Blair William & Co. IL now owns 13,523 shares of the medical equipment provider’s stock worth $3,269,000 after buying an additional 1,010 shares in the last quarter. Cetera Investment Advisers raised its position in shares of STERIS by 24.4% during the 1st quarter. Cetera Investment Advisers now owns 2,345 shares of the medical equipment provider’s stock worth $567,000 after buying an additional 460 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in shares of STERIS by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 11,525,769 shares of the medical equipment provider’s stock worth $2,786,586,000 after buying an additional 143,253 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. TheStreet upgraded shares of STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, February 8th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Friday, April 12th. KeyCorp began coverage on shares of STERIS in a research report on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price target on the stock. Finally, Stephens reaffirmed an “overweight” rating and issued a $250.00 price objective on shares of STERIS in a research note on Friday, February 9th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $239.60.

STERIS Stock Performance

Shares of STE opened at $200.71 on Friday. The firm’s 50 day moving average is $224.20 and its 200-day moving average is $217.59. The stock has a market capitalization of $19.83 billion, a P/E ratio of 35.15 and a beta of 0.79. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. STERIS plc has a 12-month low of $180.54 and a 12-month high of $254.00.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping the consensus estimate of $2.17 by $0.05. The business had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The firm’s quarterly revenue was up 14.8% compared to the same quarter last year. During the same period last year, the firm posted $2.02 earnings per share. Equities research analysts anticipate that STERIS plc will post 8.67 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Stockholders of record on Friday, February 23rd were given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend was Thursday, February 22nd. STERIS’s dividend payout ratio (DPR) is currently 36.43%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.